Unit | Health Interventions

The Health Interventions Unit deals with the development and field testing of new health interventions, with a strong focus on malaria. We operate a dual portfolio of service projects and research studies in a number of countries in Africa South of the Sahara (chiefly Tanzania, Ivory Coast and Democratic Republic of Congo) and in Papua New Guinea. Because of the very applied nature of our work, we collaborate extensively with the service departments in the institute. We also interact regularly with the Health Systems Research and Dynamical Modelling Unit, as well as with the Medical Parasitology and Infection Biology (MPI) research groups.

Research

Research work deals with the integration of new interventions into the health system (for example injectable or rectal artesunate for the treatment of severe malaria), doing trials of new vaccine candidates, developing new treatment algorithms for children with fever, improving the monitoring and evaluation of national programmes, and finally developing new vector control tools and testing them in the field. All groups also aim to strengthen capacity in malaria-endemic countries on the basis of institutional collaborative arrangements and formal training courses.

{"locations":{"0":{"title":"Centre Suisse de Recherches Scientifique CSRS, Abidjan, C\u00f4te d'Ivoire","description":"<p><a href=\"http:\/\/www.csrs.ci\" class=\"external-link-new-window\" title=\"Opens external link in new window\" data-htmlarea-external=\"1\">http:\/\/www.csrs.ci<\/a><\/p>","latitude":"5.318700","longitude":"-4.136570","projects":{}},"1":{"title":"DRC, Bagata","description":"<p><\/p>","latitude":"-3.725471","longitude":"17.939000","projects":{}},"2":{"title":"C\u00f4te d'Ivoire, Aboud\u00e9","description":"<p><\/p>","latitude":"5.897349","longitude":"-4.578381","projects":{}},"3":{"title":"Tanzania, Dodoma region","description":"<p><\/p>","latitude":"-5.8101638","longitude":"34.9258657","projects":{"0":{"uid":90,"title":"Health Promotion and Systems Strengthening Project in Dodoma Region of Tanzania, Phase I","detailUrl":"https:\/\/www.swisstph.ch\/en\/projects\/project-detail\/projectdetail-action\/detail\/projectdetail-controller\/Projects\/project\/health-promotion-and-systems-strengthening-project-in-dodoma-region-of-tanzania-phase-i\/"}}},"4":{"title":"Chronic Disease Clinic Ifakara, Tanzania","description":"<p><\/p>","latitude":"-8.145152","longitude":"36.6819253","projects":{"0":{"uid":82,"title":"CDCI - Chronic Disease Clinic Project, Ifakara","detailUrl":"https:\/\/www.swisstph.ch\/en\/projects\/project-detail\/projectdetail-action\/detail\/projectdetail-controller\/Projects\/project\/cdci-chronic-disease-clinic-project-ifakara\/"}}}}}
Selected projects at this location:

Ruffing U et al. Community-associated Staphylococcus aureus from sub-saharan Africa and Germany: a cross-sectional geographic correlation study. Sci Rep. 2017;7(1):154. DOI: 10.1038/s41598-017-00214-8

Kozycki C.T et al. False-negative malaria rapid diagnostic tests in Rwanda: impact of Plasmodium falciparum isolates lacking hrp2 and declining malaria transmission. Malar J. 2017;16(1):123. DOI: 10.1186/s12936-017-1768-1

Kozycki C.T et al. False-negative malaria rapid diagnostic tests in Rwanda: impact of Plasmodium falciparum isolates lacking hrp2 and declining malaria transmission. Malar J. 2017;16(1):123. DOI: 10.1186/s12936-017-1768-1

Fola A.A et al. Higher complexity of infection and genetic diversity of Plasmodium vivax than Plasmodium falciparum across all malaria transmission zones of Papua New Guinea. Am J Trop Med Hyg. 2017(in press). DOI: 10.4269/ajtmh.16-0716

Rodriguez-Arboli E et al. Incidence and risk factors for hypertension among HIV patients in rural Tanzania - a prospective cohort study. PLoS One. 2017;12(3):e0172089. DOI: 10.1371/journal.pone.0172089